Financhill
Sell
35

ALT Quote, Financials, Valuation and Earnings

Last price:
$5.61
Seasonality move :
-9.61%
Day range:
$5.45 - $6.01
52-week range:
$5.14 - $11.16
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
21,196.69x
P/B ratio:
3.72x
Volume:
5.9M
Avg. volume:
2.9M
1-year change:
-39.45%
Market cap:
$459.8M
Revenue:
$20K
EPS (TTM):
-$1.34

ALT Analysts' Consensus Rating

The 7 analysts providing 12-month price projections for Altimmune shares anticipate an average target of $22.38, ranging from a low estimate of $12.00 to a high estimate of $28.00. This average target implies a growth of 274.79% compared to the current stock price of $5.97.

Consensus Price Target

$22.38

Highest Price Target

$28.00

Lowest Price Target

$12.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 3 5 5

Hold 2 1 2

Sell 0 0 0
Consensus Buy Buy Buy

ALT Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock